Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
930studies shown
Showing 37-48 of 930
Drug study icon
CompletedNCT03257865

A study to Assess Brexpiprazole Versus Placebo for Acute manic episodes, Associated With Bipolarity type I

This study is completed in the United States, in Croatia, and in Ukraine. It focuses on manic episodes in bipolarity type I.

In United States
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Croatia, Ukraine
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT05340504

Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolarity

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.

Remote / online
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Bipolarity
Other study type icon
WithdrawnNCT04211428

A Non-Interventional Study to Explore the Role of Gut Flora in Bipolarity

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

In United States
Why is this study shown?

This study is directly about Bipolarity.

BipolarityOther
Countries
United States
Sponsor
ProgenaBiome
Condition
Bipolarity
Other study type icon
UnknownNCT05891639

A Close Examination of Patient Experiences in Bipolarity Clinical Trials

This study is looking at investigate the safety and efficacy of bipolarity treatments. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Why is this study shown?

This study is directly about Bipolarity.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
Power Life Sciences Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT00228059

Licarbazepine for manic episodes in bipolarity type I

This study is completed in the United States. It is testing licarbazepine for manic episodes in bipolarity type I.

In United States
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Novartis
Condition
Bipolarity
Drug study icon
CompletedNCT01358357

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

This study exists to understand how the medication Lurasidone holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication Lurasidone in practice and what may need to be adjusted.

In United States
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugOver 18 Years
Countries
United States, Australia, France, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity
Drug study icon
CompletedNCT00026585

Examination of Tamoxifen in Acute Mania in people with Bipolarity type I

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.

In United States
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity
Drug study icon
CompletedNCT00139594

Open Label Extension Study of Licarbazepine in the Treatment of manic episodes of Bipolarity type I

This study exists to understand how the medication Licarbazepine holds up over time after the earliest research stage. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

In United States
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 70 Years
Countries
United States, Canada, Austria, ...
Sponsor
Novartis
Condition
Bipolarity
Device study icon
CompletedNCT03622749

Study of Neuromodulation for Enhancement of Emotion Regulation in Bipolar Mood Disorders

This study exists to explore whether the medication Neuromodulation could improve care and understanding. Researchers are trying to understand what helps the medication Neuromodulation stay useful, realistic, and easier to follow over time.

In United States
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 55 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Bipolarity
Drug study icon
CompletedNCT00488618

Study Evaluating Cariprazine (RGH-188) in the Treatment of people with Acute Mania

This study exists to understand how the medication RGH-188 holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication RGH-188 in practice and what may need to be adjusted.

In United States
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Forest Laboratories
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.